A drug with the SMILES Cc1sc2ncn(CC(=O)N3CCN(c4ccccc4)CC3)c(=O)c2c1S(=O)(=O)N1CCOCC1 has a hERG inhibition at a concentration of 1uM of 11.361\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1sc2ncn(CC(=O)N3CCN(c4ccccc4)CC3)c(=O)c2c1S(=O)(=O)N1CCOCC1
Cc1sc2ncn(CC(=O)N3CCN(c4ccccc4)CC3)c(=O)c2c1S(=O)(=O)N1CCOCC1
6-methyl-5-morpholin-4-ylsulfonyl-3-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]thieno[2,3-d]pyrimidin-4-one